NO863338D0 - Fremgangsmaate for aa oeke loesligheten av f. eks. immunokonjugatpreparater. - Google Patents

Fremgangsmaate for aa oeke loesligheten av f. eks. immunokonjugatpreparater.

Info

Publication number
NO863338D0
NO863338D0 NO863338A NO863338A NO863338D0 NO 863338 D0 NO863338 D0 NO 863338D0 NO 863338 A NO863338 A NO 863338A NO 863338 A NO863338 A NO 863338A NO 863338 D0 NO863338 D0 NO 863338D0
Authority
NO
Norway
Prior art keywords
solubility
immunoconjugate
weekly
procedure
anionic detergent
Prior art date
Application number
NO863338A
Other languages
English (en)
Other versions
NO168989B (no
NO168989C (no
NO863338L (no
Inventor
A Charles Morgan Jr
Gowsala Pavanasasivam
Original Assignee
Neorx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neorx Corp filed Critical Neorx Corp
Publication of NO863338D0 publication Critical patent/NO863338D0/no
Publication of NO863338L publication Critical patent/NO863338L/no
Publication of NO168989B publication Critical patent/NO168989B/no
Publication of NO168989C publication Critical patent/NO168989C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO863338A 1985-08-20 1986-08-19 Fremgangsmaate for aa oeke loeseligheten av f. eks. immunokonjugatpreparater NO168989C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76749385A 1985-08-20 1985-08-20

Publications (4)

Publication Number Publication Date
NO863338D0 true NO863338D0 (no) 1986-08-19
NO863338L NO863338L (no) 1987-02-23
NO168989B NO168989B (no) 1992-01-20
NO168989C NO168989C (no) 1992-04-29

Family

ID=25079669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863338A NO168989C (no) 1985-08-20 1986-08-19 Fremgangsmaate for aa oeke loeseligheten av f. eks. immunokonjugatpreparater

Country Status (7)

Country Link
EP (1) EP0213881B1 (no)
JP (1) JPS62181224A (no)
AT (1) ATE97324T1 (no)
CA (1) CA1306194C (no)
DE (1) DE3689299T2 (no)
DK (1) DK398086A (no)
NO (1) NO168989C (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4926869A (en) * 1986-01-16 1990-05-22 The General Hospital Corporation Method for the diagnosis and treatment of inflammation
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US4946675A (en) * 1987-05-27 1990-08-07 Xoma Corporation Hepatic blocking agents
CN104370997B (zh) * 2014-09-24 2018-07-31 陈辉 去除生物制品中细菌内毒素的试剂盒、方法及其生物制品的制备方法
EP4244625A1 (en) * 2020-11-13 2023-09-20 Beckman Coulter, Inc. Additives for reducing non-specific interactions between fluorescent polymer conjugates and cells in a biological sample

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2927103A1 (de) * 1978-10-06 1980-04-17 Baxter Travenol Lab Optisches verfahren zur bestimmung von endotoxin
US4460559A (en) * 1980-03-03 1984-07-17 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers

Also Published As

Publication number Publication date
NO168989B (no) 1992-01-20
JPS62181224A (ja) 1987-08-08
EP0213881A3 (en) 1987-09-16
DK398086D0 (da) 1986-08-20
DE3689299D1 (de) 1993-12-23
ATE97324T1 (de) 1993-12-15
DE3689299T2 (de) 1994-03-10
EP0213881A2 (en) 1987-03-11
DK398086A (da) 1987-02-21
CA1306194C (en) 1992-08-11
NO168989C (no) 1992-04-29
NO863338L (no) 1987-02-23
EP0213881B1 (en) 1993-11-18

Similar Documents

Publication Publication Date Title
DK499086A (da) Konjugater af trichothecen og anvendelse af samme som terapeutisk substans
DE68921941D1 (de) Macrocyclische bifunktionelle Chelatbildner, Komplexe davon und ihre konjugierten Antikörper.
KR850000248A (ko) 이뮤노톡신 결합체의 제조방법
ATE162403T1 (de) Modifizierte antikörper mit kontrollierter clearance-zeit
DE69132055T2 (de) Ortsgenaue konjugatbildung zwischen immunglobulinen und nachweisbaren markierungsstoffen
TR199701547T1 (xx) Polisakarit antijen protein e�leni�i i�eren a��.
DE3588210D1 (de) Biologisch nützliche Konjugate
ATE58297T1 (de) Kupplungsmittel zum radiomarkieren von proteinen.
ES520692A0 (es) Un procedimiento de preparacion de conjugados inmunoenzimaticos.
MY104946A (en) Antigen antibody conjugate.
FI950062A (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
NO168989C (no) Fremgangsmaate for aa oeke loeseligheten av f. eks. immunokonjugatpreparater
NZ221065A (en) Conjugates of antibodies and toxins with sulphur-containing linking groups
ATE193534T1 (de) Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden
ATE162217T1 (de) Arylsulfatase
ATE178493T1 (de) Stabilisierte antikörperfragmente